BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1369 related articles for article (PubMed ID: 7834738)

  • 1. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.
    Marshall CJ
    Cell; 1995 Jan; 80(2):179-85. PubMed ID: 7834738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for MEK-independent pathways regulating the prolonged activation of the ERK-MAP kinases.
    Grammer TC; Blenis J
    Oncogene; 1997 Apr; 14(14):1635-42. PubMed ID: 9135064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphotyrosine residues in the nerve-growth-factor receptor (Trk-A). Their role in the activation of inositolphospholipid metabolism and protein kinase cascades in phaeochromocytoma (PC12) cells.
    Baxter RM; Cohen P; Obermeier A; Ullrich A; Downes CP; Doza YN
    Eur J Biochem; 1995 Nov; 234(1):84-91. PubMed ID: 8529673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways.
    Kilgour E; Gout I; Anderson NG
    Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):517-22. PubMed ID: 8615823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase 2 (ERK-2) and c-Jun N-terminal kinase (JNK) signal cascades in airway smooth muscle.
    Pyne S; Chapman J; Steele L; Pyne NJ
    Eur J Biochem; 1996 May; 237(3):819-26. PubMed ID: 8647130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
    Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
    Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.
    Xia Z; Dickens M; Raingeaud J; Davis RJ; Greenberg ME
    Science; 1995 Nov; 270(5240):1326-31. PubMed ID: 7481820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parietal cell MAP kinases: multiple activation pathways.
    Nakamura K; Zhou CJ; Parente J; Chew CS
    Am J Physiol; 1996 Oct; 271(4 Pt 1):G640-9. PubMed ID: 8897883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
    Hagemann D; Troppmair J; Rapp UR
    Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF-1 signal transduction.
    Hamilton JA
    J Leukoc Biol; 1997 Aug; 62(2):145-55. PubMed ID: 9261328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle.
    Aronson D; Violan MA; Dufresne SD; Zangen D; Fielding RA; Goodyear LJ
    J Clin Invest; 1997 Mar; 99(6):1251-7. PubMed ID: 9077533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.
    Penuel E; Martin GS
    Mol Biol Cell; 1999 Jun; 10(6):1693-703. PubMed ID: 10359590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of mitogen-activated protein kinases by a mammalian tyrosine-specific phosphatase, PTPBR7.
    Ogata M; Oh-hora M; Kosugi A; Hamaoka T
    Biochem Biophys Res Commun; 1999 Mar; 256(1):52-6. PubMed ID: 10066421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mitogen-activated protein kinase activation by naturally occurring splice variants of TrkC, the receptor for neurotrophin-3.
    Gunn-Moore FJ; Williams AG; Tavaré JM
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):193-8. PubMed ID: 9078261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose transporter expression in L6 muscle cells: regulation through insulin- and stress-activated pathways.
    Taha C; Tsakiridis T; McCall A; Klip A
    Am J Physiol; 1997 Jul; 273(1 Pt 1):E68-76. PubMed ID: 9252481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms.
    DĂ©rijard B; Raingeaud J; Barrett T; Wu IH; Han J; Ulevitch RJ; Davis RJ
    Science; 1995 Feb; 267(5198):682-5. PubMed ID: 7839144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
    EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.